The Biologics News and Reports Portal

Show Cart

All Products

Results 101 - 120 of 171

Sep 2014 Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

200.00 €

Aug 2014 Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

350.00 €

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

1,462.50 €

1,950.00 €

(Discount: 25.00%)

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

200.00 €

Jun 2014 Competitor Analysis: Phosphodiesterase 4 (PDE-4) Inhibitors

200.00 €

Mar 2014 Competitor Analysis: Cancer Vaccines

800.00 €

Mar 2014 2013 Sales of Recombinant Therapeutic Antibodies & Proteins

25.00 €

Jan 2014 Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis

2,150.00 €

Jan 2014 Competitor Analysis: Immunocytokines

250.00 €

Nov 2013 Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

400.00 €

Oct 2013 Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

500.00 €

Oct 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

1,450.00 €

Sep 2013 Competitor Analysis: Pim Kinase Inhibitors

150.00 €

Sep 2013 Competitor Analysis: Wnt Pathway Inhibitors

100.00 €

Aug 2013 Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors

100.00 €

Currencies

Shopping cart

Cart empty

Latest report

Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway & STING 2018

Featured Products

Report Package: TCR-Based Antibody and T-Cell Immunotherapy

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

Latest Target Pipeline

Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Currencies

Shopping cart

Cart empty

Latest report

Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway & STING 2018

Featured Products

Report Package: TCR-Based Antibody and T-Cell Immunotherapy

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

All Products

Nov 2014 Competitor Analysis: Cardiometabolic Peptides

Oct 2014 Competitor Analysis: Ebola Virus Vaccines and Therapeutics

Oct 2014 Competitor Analysis: Anti-Infective Peptides

Oct 2014 Competitor Analysis: Cardiovascular Peptides

Sep 2014 Competitor Analysis: Anti-Inflammatory Peptides

Sep 2014 Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

Aug 2014 Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

Jun 2014 Competitor Analysis: Phosphodiesterase 4 (PDE-4) Inhibitors

Mar 2014 Competitor Analysis: Cancer Vaccines

Mar 2014 2013 Sales of Recombinant Therapeutic Antibodies & Proteins

Jan 2014 Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis

Jan 2014 Competitor Analysis: Immunocytokines

Nov 2013 Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

Oct 2013 Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

Oct 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

Sep 2013 Competitor Analysis: Pim Kinase Inhibitors

Sep 2013 Competitor Analysis: Wnt Pathway Inhibitors

Aug 2013 Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors

Currencies

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Currencies

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing